When someone is diagnosed with breast cancer, doctors often discuss both the stage and the grade of the disease. While stage describes how far the cancer has spread in the body, grade refers to how abnormal
the cancer cells look under a microscope and how quickly they are likely to grow.
Understanding these grades can help patients better grasp the nature of their diagnosis and the treatment approach recommended by their doctors. Although hearing terms like Grade 1, 2 or 3 can feel overwhelming, experts say these classifications simply help doctors assess how aggressive a tumour may be.
“Grade 1 is regarded as the least aggressive form of breast cancer. The cells closely resemble normal cells and grow slowly,” explains Dr. Bhavisha Ghugare, Senior Consultant Surgical Breast Oncology at HCG Cancer Centre, Borivali, Mumbai. Meanwhile, Dr. Sushil Modkharkar, Consultant Histopathologist at Dr L H Hiranandani Hospital, Mumbai, explains that breast cancer grading is determined using the internationally recognised Nottingham Grading System. “This system evaluates the tumour tissue under a microscope to understand how aggressive the cancer might be,” he says.
What Doctors Mean By Breast Cancer Grades
Cancer grading is essentially a microscopic evaluation performed by pathologists. The goal is to understand how closely cancer cells resemble healthy breast cells and how quickly they are dividing.
According to Dr. Modkharkar, the Nottingham system assesses three important features: tubule formation, nuclear pleomorphism and mitotic count. Tubule formation measures how much the tumour resembles normal breast ducts, while nuclear pleomorphism evaluates how abnormal the cell nuclei appear. Mitotic count indicates how rapidly the cells are dividing.
These factors together help determine whether the tumour is classified as Grade 1, Grade 2 or Grade 3.
Grade 1: The Least Aggressive Form
Grade 1 breast cancer is considered low-grade and generally grows slowly. According to Dr. Ghugare, these cancer cells look quite similar to normal cells and tend to spread less quickly. Because of their slower growth pattern, Grade 1 tumours often respond well to treatment when detected early. Early screening and timely medical intervention can lead to excellent outcomes for many patients diagnosed at this stage.
Grade 2: The Intermediate Stage
Grade 2 breast cancer falls between low-grade and high-grade tumours. The cells appear more abnormal than those in Grade 1 and grow at a moderate pace. Dr. Ghugare explains that Grade 2 tumours represent an intermediate category, meaning their behaviour and growth rate typically fall between the slower Grade 1 cancers and the faster-growing Grade 3 tumours.
Grade 3: Faster-Growing Cancer Cells
Grade 3 breast cancer, also known as high-grade cancer, involves cells that look very different from normal breast tissue. These cells tend to grow and divide more rapidly.
Because of this accelerated growth, Grade 3 tumours may have a greater potential to spread compared to lower-grade cancers. However, doctors stress that grade alone does not determine the overall outlook.
Why Grade Is Only One Part Of The Picture
While tumour grade is important, doctors also consider several other factors before determining treatment or prognosis. Dr. Ghugare explains, “Tumour size, stage of cancer, lymph node involvement, hormone receptor status, HER2 markers and the patient’s overall health all influence outcomes.”
Dr. Modkharkar also highlights the importance of early detection, noting that low-grade tumours often develop gradually and may be detected through routine screening before they progress. Hormonal and genetic factors can also affect breast cancer development. For instance, early menstruation, late menopause or hormonal changes after menopause may influence risk levels in some women.
The Role Of Early Detection
Understanding breast cancer grades helps patients and doctors make informed decisions about treatment and monitoring. While higher-grade tumours may require more aggressive therapy, early detection remains one of the most effective tools in improving outcomes.
Regular screening, awareness of risk factors and timely medical consultation continue to play a crucial role in identifying breast cancer before it advances.
